Article
Pretreatment heterogeneous enhancement pattern of hepatocellular carcinoma can be new predictor for early response to lenvatinib
2019-07-03
Abstract excerpt
<title>Abstract</title> <p>Background: The aims of this study were to identify useful predictors of early tumor response to lenvatinib, and to evaluate the utility of estimation of tumor differentiation from pretreatment image analysis. <h4>Methods:</h4> We evaluated 37 consecutive patients with unresectable hepatocellular carcinoma (HCC) diagnosed by dynamic computed tomography (CT) who received lenvatinib. Pret...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f8778140-ce6c-57c7-b744-f6ea3fa4fb1f
- DOI
- 10.21203/rs.2.10911/v1
